非裔美国人(45-50岁)在基于粪便免疫化学检测的结直肠癌筛查项目中的早期筛查
这项前瞻性研究分析了Kaiser Permanente北加州健康计划中非裔美国会员的FIT筛查数据,比较2018年45-50岁早期筛查组与51-56岁既往未筛查的非裔美国人、白人、西班牙裔及亚裔/太平洋岛民会员。早期筛查组FIT完成率33.1%,阳性者中85.3%完成结肠镜随访,57.8%发现任何腺瘤,33.6%发现进展期腺瘤,2.6%诊断为结直肠癌。早期筛查组完成筛查的可能性略高于51-56岁各比较组,各组FIT阳性率(范围3.8%-4.6%)及腺瘤/进展期腺瘤/结直肠癌检出率相似。
要点
- 45-50岁非裔美国人FIT筛查完成率33.1%,阳性者85.3%完成结肠镜随访。
- 早期筛查组FIT阳性者中57.8%有任何腺瘤,33.6%有进展期腺瘤,2.6%诊断为结直肠癌。
- 早期筛查组筛查完成率略高于51-56岁既往未筛查的非裔、白人、西班牙裔及亚裔/太平洋岛民,各组FIT阳性率和检出率相似。
核心结论
- 45-50岁非裔美国人参与早期FIT筛查的比例及检测检出率与51-56岁既往未筛查的非裔美国人、白人、西班牙裔及亚裔/太平洋岛民相当。
研究设计与样本
- 前瞻性研究,纳入Kaiser Permanente北加州健康计划中2018年45-50岁接受FIT筛查的非裔美国会员(早期筛查组),并与51-56岁既往未筛查的非裔美国人、白人、西班牙裔及亚裔/太平洋岛民会员比较。
- 通过邮寄FIT试剂盒进行筛查外展,采用校正性别的逻辑回归模型评估组间筛查完成率、异常结果结肠镜随访及检测检出率的差异。
主要发现
- 早期筛查组10232名非裔美国人中,FIT筛查完成率为33.1%。
- FIT阳性者(4%)中85.3%完成结肠镜随访:57.8%有任何腺瘤,33.6%有进展期腺瘤(伴有高级别组织学或息肉≥10 mm的腺瘤),2.6%诊断为结直肠癌。
- 早期筛查组完成筛查的可能性略高于51-56岁既往未筛查的非裔美国人、白人和西班牙裔。
- 各组FIT阳性率无显著差异(范围3.8%-4.6%),阳性后结肠镜随访率超过74%。
- 任何腺瘤(范围56.7%-70.7%)、进展期腺瘤(范围20.0%-33.6%)和结直肠癌(范围0%-7.1%)的检出率相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Some guidelines recommend starting colorectal cancer (CRC) screening before age 50 years for African Americans, but there are few data on screening uptake and yield in this population. METHODS: We performed a prospective study of fecal immunochemical test (FIT) screening among African American members of the Kaiser Permanente Northern California health plan. We compared data from African American members screened when they were 45-50 years old (early screening group) in 2018 with data from previously unscreened African American, white, Hispanic, and Asian/Pacific Islander health plan members who were 51-56 years old. Screening outreach was performed with mailed FIT kits. Logistic regression models, adjusted for sex, were used to evaluate differences among groups in screening uptake, colonoscopy follow-up of abnormal test results, and test yield. RESULTS: Among 10,232 African Americans in the early screening group who were mailed a FIT, screening was completed by 33.1%. Among the 4% with positive test results, 85.3% completed a follow-up colonoscopy: 57.8% had any adenoma, 33.6% had an advanced adenoma (adenoma with advanced histology or polyp ≥10 mm), and 2.6% were diagnosed with CRC. African Americans in the early screening group were modestly more likely to have completed screening than previously unscreened African Americans, whites, and Hispanics 51-56 years old. The groups did not differ significantly in positive results from the FIT (range, 3.8%-4.6%) and more than 74% received a follow-up colonoscopy after a positive test result. The test yields for any adenoma (range, 56.7%-70.7%), advanced adenoma (range, 20.0%-33.6%), and CRC (range, 0%-7.1%) were similar. CONCLUSIONS: Proportions of African Americans who participated in early (aged 45-50 years) FIT screening and test yield were comparable to those of previously unscreened African Americans, whites, Hispanics, and Asian/Pacific Islanders who were 51-56 years old.
引用
- Levin TR, Jensen CD, Chawla NM, et al. Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program. Gastroenterology. 2020. PMID: 32702368. doi:10.1053/j.gastro.2020.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。